NasdaqGS - Delayed Quote USD
REGENXBIO Inc. (RGNX)
At close: November 5 at 4:00 PM EST
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
28.9
ESG Risk Score for Peers
| Name | Total ESG Risk score | E | S | G |
|---|---|---|---|---|
| NTRA Natera, Inc. | 30 | 1 | 21 | 7 |
| TNGX Tango Therapeutics, Inc. | 30 | -- | -- | -- |
| RGNX REGENXBIO Inc. | 29 | -- | -- | -- |
| JANX Janux Therapeutics, Inc. | 29 | -- | -- | -- |
| GLUE Monte Rosa Therapeutics, Inc. | 29 | -- | -- | -- |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 10/2024
RGNX
Category Average
N/A None Controversy Level
None 4 Severe
-- RGNX
0.4 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
| Products and Activities | Significant Involvement |
|---|---|
| Alcoholic Beverages | No |
| Adult Entertainment | No |
| Gambling | No |
| Tobacco Products | No |
| Animal Testing | Yes |
| Fur and Specialty Leather | No |
| Controversial Weapons | No |
| Small Arms | No |
| Catholic Values | No |
| GMO | No |
| Military Contracting | No |
| Pesticides | No |
| Thermal Coal | No |
| Palm Oil | No |
Related Tickers
QURE uniQure N.V.
6.06
+8.99%
MGTX MeiraGTx Holdings plc
6.22
+4.36%
VRDN Viridian Therapeutics, Inc.
23.29
+1.97%
VYGR Voyager Therapeutics, Inc.
6.65
0.00%
DNLI Denali Therapeutics Inc.
27.65
+1.62%
APLS Apellis Pharmaceuticals, Inc.
28.08
-1.70%
ADVM Adverum Biotechnologies, Inc.
7.72
+2.39%
ANAB AnaptysBio, Inc.
19.88
-0.30%
CLSD Clearside Biomedical, Inc.
1.0700
+3.88%
ITOS iTeos Therapeutics, Inc.
9.22
+2.79%